Alopecia

Posts

PRP Workshop To Enhance Hair Restoration

Stem Cell and Platelet Rich Plasma

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market report focused on the comprehensive analysis of current and future prospects of the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies industry.

This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and micro environmental factors.

An in-depth analysis of past trends, future trends, demographics, technological advancements, and regulatory requirements for the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market has been done in order to calculate the growth rates for each segment and sub-segments.

Top Key Vendors of this Market are:

Orange County Hair Restoration Center, Colorado Surgical Center& Hair Institute, Evolution Hair Loss Institute, Hair Sciences Center of Colorado, Hair Transplant Institute of Miami, Anderson Center for Hair, Virginia Surgical Center, Savola Aesthetic Dermatology Center

Various factors are responsible for the market’s growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.

It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market’s trajectory between forecast periods.

The report provides insights on the following pointers:

  1. Market Penetration: Comprehensive information on the product portfolios of the top players in the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.
  2. Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.
  3. Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
  4. Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
  5. Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.

The report summarized the high revenue that has been generated across locations like, North America, Japan, Europe, Asia, and India along with the facts and figures of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market. It focuses on the major points, which are necessary to make positive impacts on market policies, international transactions, speculation, and supply demand in the global market.

Reasons for buying this report:

  • It offers an analysis of changing competitive scenario.
  • For making informed decisions in the businesses, it offers analytical data with strategic planning methodologies.
  • It offers a seven-year assessment of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market.
  • It helps in understanding the major key product segments.
  • Researchers throw light on the dynamics of the market such as drivers, restraints, trends, and opportunities.
  • It offers the regional analysis of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market along with business profiles of several stakeholders.
  • It offers massive data about trending factors that will influence the progress of the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market.

Table of Contents

Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Research Report 2020 – 2026

Chapter 1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Forecast

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market

Source

Previous Post

PRP Workshop To Enhance Hair Restoration

Stem Cell and Platelet Rich Plasma

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market report focused on the comprehensive analysis of current and future prospects of the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies industry.

This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and micro environmental factors.

An in-depth analysis of past trends, future trends, demographics, technological advancements, and regulatory requirements for the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market has been done in order to calculate the growth rates for each segment and sub-segments.

Top Key Vendors of this Market are:

Orange County Hair Restoration Center, Colorado Surgical Center& Hair Institute, Evolution Hair Loss Institute, Hair Sciences Center of Colorado, Hair Transplant Institute of Miami, Anderson Center for Hair, Virginia Surgical Center, Savola Aesthetic Dermatology Center

Various factors are responsible for the market’s growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.

It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market’s trajectory between forecast periods.

The report provides insights on the following pointers:

  1. Market Penetration: Comprehensive information on the product portfolios of the top players in the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.
  2. Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.
  3. Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
  4. Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
  5. Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.

The report summarized the high revenue that has been generated across locations like, North America, Japan, Europe, Asia, and India along with the facts and figures of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market. It focuses on the major points, which are necessary to make positive impacts on market policies, international transactions, speculation, and supply demand in the global market.

Reasons for buying this report:

  • It offers an analysis of changing competitive scenario.
  • For making informed decisions in the businesses, it offers analytical data with strategic planning methodologies.
  • It offers a seven-year assessment of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market.
  • It helps in understanding the major key product segments.
  • Researchers throw light on the dynamics of the market such as drivers, restraints, trends, and opportunities.
  • It offers the regional analysis of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market along with business profiles of several stakeholders.
  • It offers massive data about trending factors that will influence the progress of the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market.

Table of Contents

Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Research Report 2020 – 2026

Chapter 1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Forecast

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market

Source

Previous Post

Thinning Hair and Hair Loss Product Market

Trial for Androgenic Alopecia in Men

Trial for Androgenic Alopecia in Men

The global hair transplant market size was USD 5.94 billion in 2018 and is projected to reach USD 43.13 billion by 2026, exhibiting a CAGR of 28.1% during the forecast period.

We are in process of revamping Hair Transplant Market with respect to COVID-19 Impact.

The hair transplant industry has rapidly undergone a pioneering transformation over the years. From the traditional Follicular Unit Transplantation (FUT) to Follicular Unit Extraction (FUE), the market has witnessed several technological advancements. Yet, it is still controversial for the physicians which transplantation method is the best so far.

Moreover, non-surgical procedures are also coming up with numerous advancements in medical devices for hair loss treatment. Pharmaceutical companies are focusing on R&D to launch an effective drug to assist hair loss.

As alopecia (commonly known as baldness) is very common among the populations in Asia Pacific and the Middle East & Africa, the hair restoration market is expected to exhibit an upsurging demand during the forecast period. In addition, growing investments in integrating robotics with transplantation technologies would also contribute to the faster growth of the market in the coming years.

Technological Advancements in Robotic Hair Transplantation to Propel Market Growth

Since the introduction of robotic hair transplantation, there have been continuous improvements in technology. Transplantation centres and top clinics are putting efforts into increasing the sophistication of the technique to yield effective treatment outputs. These efforts are facilitating market growth to a greater extent.

For example, recently in 2018, Restoration Robotics launched a 9x ARTAS robotic transplant system. The 9x ARTAS is the fastest and most accurate than the previous ARTAS version having better functionality. It has also been coupled with artificial intelligence (AI) to improve productivity and enhance system capabilities. Such technological advancements in the hair restoration industry would help grab a greater number of patients and yield better revenue during the forecast period.

Rapid Expansion of Patient Pool with Higher Disposable Income to Proliferate Market Potential

Due to the rapid advancements in the hair transplantation market, nearly all men and women who have alopecia can be successfully treated with these transplantation techniques. This achievement of the market has led to an increase in the patient population.

In the current scenario of the developing economies due to rising disposable income, men and women are largely spending on aesthetic procedures. This has led to the growth of the hair restoration market over the years.

According to the American Society of Aesthetic Plastic Surgery in 2016, Americans spent approximately USD 15 billion on surgical as well as non-surgical aesthetic procedures. Furthermore, based on the survey of Kaya Limited, there is a strong potential market in India owing to its rising disposable income and aspirational middle-class population.

Thus, considering the above points, it is anticipated that the hair restoration market has proliferative growth during the forecast period.

Increasing Prevalence of Androgenic Alopecia to Fuel Market Growth

Hair transplantation is the most common surgery performed in men worldwide. Androgenic alopecia is the term used for hair loss in men. According to the International Society of Hair Restoration Surgery (ISHRS), every year, approximately 35 million men in the U.S. are affected by male pattern baldness.

This increasing prevalence is likely to captivate patients towards hair restoration techniques and treatment options. Additionally, the launch of novel techniques and effective products are also expected to magnetize the patient population towards the hair transplant market during the forecast period. According to ISHRS, owing to the rising prevalence rates of alopecia, hair restoration procedures have been increased by 60% since 2014.

Out of the total surgeries performed, 87% of the patients are men. Therefore, increasing patient population and prevalence of androgenic alopecia are anticipated to elicit tremendous growth of the market during the forecast period.

High Surgical Procedure Cost to Limit the Growth of the Global Market

Even though transplantation technology has proved its effectiveness in restoring hair, the high cost of the procedure is likely to restrain the market growth. The transplantation procedure cost varies depending on the type of surgical technique preferred.

For instance, according to a study conducted by Robotics, average transplantation cost in the U.S. is around $16,000 and is highest among the other countries. Additionally, the average spending in developing countries such as India is around $3,000. Thus, the high procedure cost is unaffordable by the middle-income population of the countries and will limit the adoption of surgical procedures.

Higher Sales of Non-Surgical Hair Transplant Products to Lead Dominance

Based on type, the market is segmented into surgical and non-surgical. The non-surgical segment dominated the global market in terms of value and market share in 2018. The non-surgical restoration procedure is more advantageous as compared to that of the surgical procedure owing to its lesser side effects and instant results.

Due to such advantages, people are more attracted towards non-surgical hair transplantation. For instance, according to a survey conducted by the International Society of Hair Restoration Surgery (ISHRS), worldwide 1,241,764 patients for the non-surgical procedure were recorded in 2017. The sales of medications, devices to combat hair loss, and adoption of non-surgical techniques had led to the dominance of the segment in 2018.

On the flip side, though the surgical procedure segment had a lower market share in 2018, it is anticipated to gain traction during the forecast period. The segmental rise is attributable to the effectiveness of the surgical procedure. This segment is anticipated to have the highest CAGR and mark an exponential growth during the forecast period.

Adoption of Hair Transplants by Males to Aid Greater Market Share

Based on gender, the market is classified into male and female. The male segment dominated the global market in 2018. This dominance is attributed to the increasing number of surgeries undertaken by males all over the globe. The adoption of surgeries by the male segment of the population is higher owing to the occurrence of alopecia in 60% of the male than the female population.

A similar scenario is observed for the non-surgical procedures as well. For example, according to the data recorded by ISHRS in 2017, 85.7% of the male patients underwent surgical transplantation while 61.8% of the male patients underwent non-surgical procedures. The rising prevalence of alopecia in males is anticipated to mark the highest CAGR for the male segment during the forecast period.

Moreover, the female segment has recorded a lower hair transplant market share. Steady growth is anticipated during the forecast period owing to the lesser preference of females for transplantation of hair.

Growing Surgeries in Hospitals and Specialty Clinics to Aid Higher Market Value

By end-user, the global market is classified into hospitals & clinics and hair transplant centers. In 2018, the hospitals & clinics segment held the leading position in the market. The dominance is attributed to factors such as higher investments in infrastructure management and growing demand for surgical procedures by the patient population at hospitals and clinics. The hospitals and clinics have a well-established medical infrastructure and thus are of greater preference for the patient population.

The newly launched systems are adopted and installed by the hospitals and clinics in a short duration due to the availability of adequate funds. For instance, the popular ARTAS system by Restoration Robotics was sold in more than 37 countries globally to different hospitals and physicians.

On the other hand, these transplant centers segment is anticipated to showcase a slower growth during the forecast period owing to the generation of lower revenue by the centers. Also, a lack of awareness about the hair transplantation centers in the patient population would hinder the growth.

On the geographical front, the global market was dominated by Asia Pacific in 2018 in terms of market share and market value. The hair transplant market in Asia Pacific was valued at USD 1.88 billion in 2018. The primary factor responsible for the leading position is the highest number of transplantation surgeries of hair performed in the region. According to several research studies conducted by researchers, the populations in Asia Pacific have higher prevalence and chances of alopecia.

This has made the region a potential market for the investors. Additionally, the surgeries performed in the region have led to a generation of higher revenue leading to its dominance. Moreover, the establishment of hair transplant facilities in the region, coupled with higher investments in the advancements of the transplantation systems is contributing to the regional growth of Asia Pacific. Thus, the above factors are responsible to boost the region during the forecast period. The Middle East & Africa holds the second position in the market owing to the availability of the hair transplantation procedures at a lower value. This has led to the adoption of surgical procedures by the MEA population. However, the other factor contributing to the MEA market growth is the growing popularity of hair transplant surgery in Turkey.

On the other hand, North America and Europe are likely to exhibit a considerably lower market growth owing to a lower prevalence of alopecia in the countries and lesser adoption of these transplantation techniques.

Continuous Development of the Hair Transplant Systems Has Led Venus Concept a Leader

The global hair transplant market is fragmented into companies ranging from start-ups to well-established leaders. These market players are continuously focused on developing innovative products to achieve effective transplant procedures and positive outcomes.

Venus Concept has surpassed the other players through rigorous developments and launching of surgical as well as non-surgical treatment products. ARTAS iX robotic system has become one of the most demanding systems worldwide. This system helps to assist physicians in identifying and extracting hair follicular units from the scalp of the alopecia patients. Venus Concept after merging with Restoration Robotics Inc. brought this ARTAS system and has leveraged its potential in the hair restoration market.

Trial for Androgenic Alopecia in Men

Source

Previous Post

Alopecia Treatment Market

Global Alopecia Market

Global Alopecia Market Research Report 2020 Analysis, Demand, Insight, Key Players, Segmentation and Forecast to 2025

Eon Market Research has added a report titled “Global Alopecia (Hair Loss Treatment) Market Research Report 2020 Analysis, Demand, Insight, Key Players, Segmentation and Forecast to 2025”. The report will include the impact of COVID 19 and its impact on the growth of this industry during the forecast period.

The Alopecia (Hair Loss Treatment) market report offers the growth scenarios present globally as well as revenues of the overall market. The Global Alopecia (Hair Loss Treatment) market report thoroughly discusses robust growth prospects and prominent strategies implicated by several key players operating in the global market, which are likely to benefit the market growth and grab a leading position in terms of revenue in the Alopecia (Hair Loss Treatment) market.

In this report, the global Alopecia (Hair Loss Treatment) market is estimated at USD XX million in 2020 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2020 and 2025.

Geographically, this report is segmented into various key Regions

North America
Europe
China
Japan
Southeast Asia
India

Global Alopecia (Hair Loss Treatment) market competition

Shiseido
Rohto
Unilever
Taisho
Angfa
LOreal
Kaminomoto
Merck
Yanagiya Honten
Amorepacific
Procter and Gamble
Himalaya
Gerolymatos International
Merz Pharma
Leader Teck
Vasu Healthcare
VLCC
Ales Group
Shanxi Ante
Wansheng Pharmaceutical
Advanced Skin and Hair
Humanwell Healthcare
Topfond
Lifes2good
Bawang
YNK Pharmaceutical
Apollo
Jingxiutang
Rogaine
Marico

Based on product

Shampoos and Conditioners
Medicine Product

Based on the end users/applications

Men
Women

Global Alopecia Market Research Report 2020 Analysis, Demand, Insight, Key Players, Segmentation and Forecast to 2025

Source

Previous Post

Alopecia Treatment Market

Global Alopecia Market Insights

Global Alopecia Market Insights and Forecast to 2026

Alopecia market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alopecia market will be able to gain the upper hand as they use the report as a powerful resource.

The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Alopecia market is segmented into

Oral treatment
Topical treatment
Other treatment

Segment by Application, the Alopecia market is segmented into

Male
Female

Regional and Country-level Analysis

The Alopecia market is analysed and market size information is provided by regions (countries).

The key regions covered in the Alopecia market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes a country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Alopecia Market Share Analysis

Alopecia market competitive landscape provides details and data information by players. The report offers a comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020.

It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Alopecia business, the date to enter into the Alopecia market, Alopecia product introduction, recent developments, etc.

The major vendors covered:

Lifes2good
Kirkland Signature
Johnson & Johnson
Dr Reddys Laboratories.
Cipla.
Alpecin.
Vitabiotics.
Sun Pharma.
Phyto Ales Group

Global Alopecia Market Insights and Forecast to 2026

Source

Previous Posts

Alopecia Treatment Market

Androgenic Alopecia Global Clinical Trials

Androgenic Alopecia Global Clinical Trials Review, H1, 2020

Summary

The clinical trial report, “Androgenic Alopecia Global Clinical Trials Review, H1, 2020″ provides an overview of Androgenic Alopecia Clinical trials scenario. This report provides top-line data relating to the clinical trials on Androgenic Alopecia.

The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.

The report also provides prominent drugs for in-progress trials (based on a number of ongoing trials). Clinical Trial Reports are generated using proprietary database – Pharma – Clinical trials database.

Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision-making capabilities and helps to create an effective counter-strategy to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– The report provides top-level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with a reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– The report provides the latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Androgenic Alopecia Global Clinical Trials Review, H1, 2020

Source

Previous Posts

Robotic Hair Transplant System Market

Robotic Hair Transplant System Market

Robotic Hair Transplant System Market Forecast, Trend Analysis & Competition Tracking – Global Review 2018 to 2028

Alopecia or hair loss is a chronic dermatology disease in which there is either partial or complete loss of hair from the scalp and other parts of the body.

According to the National Alopecia Areata Foundation, approximately 6.8 million people in the United States and 147 million worldwide have developed alopecia at some point in time.

A strong family history is one of the main reasons contributing towards pattern baldness or androgenic alopecia in both males and females. As estimated by the International Society of Hair Restoration Surgery (ISHRS), more than 35 million men in the U.S. currently suffer from male pattern baldness. ARTAS robotic hair transplant systems make the hair translation procedure more effective and less painful.

The ARTAS robotic hair transplant system is a computer-assisted equipment use to improve the quality of follicle. It also enhances the quality of the most challenging Follicle Extraction Unit (FUE). Various components of an ARTAS robotic hair transplant system are image-guided robotic arm, small dermal punches and a computer interface.

artas

The robot is guided by a 3-D imaging software and the cameras. The device removes the hair follicle at a rate of 1,000 per hour. The FUE procedure involves removing hair from the donor region of the scalp and then implanting it into the recipient site. The separation of the follicular units from the donor tissue is a tedious, repetitive and labour intensive process. The FUE process requires great precision to prevent damage to follicular units.

The ARTAS robotic hair transplant system has significantly increased the accuracy of the FUE procedure. The ARTAS robotic hair transplant system reduces harvesting time and minimizes any damage to hair follicles with its efficacy and great precision. The ARTAS robotic hair transplant system also improves the chances of graft survival. It is also far more comfortable than traditional and more invasive hair restoration processes.

Robotic Hair Transplant System Market: Drivers and Restraints

Increasing prevalence of various dermatological related disorders will drive the robotic hair transplant system market during the forecast period. Unhealthy lifestyle patterns and an increase in stress levels will further contribute towards the growth of hair restoration treatment and robotic hair transplant systems market.

Genetic and other environmental factors increase baldness among men and women. Technologically improved and minimally invasive transplant treatment methods will increase the growth of the robotic hair transplant system market during the forecast period.

High adoption among people of young age to enhance their appearance will further fuel the overall market of robotic hair transplant systems. However, high cost and various side effects associated with the treatment, such as the itchy scalp, hair thinning, etc., might hinder the growth of the robotic hair transplant system market during the forecast period.

Robotic Hair Transplant System Market: Segmentation

The robotic hair transplant system market can be segmented on the basis of end-user and region. Based on end-user, the hair transplant system market is segmented as:

  • Dermatology Clinics
  • Hospitals

Robotic Hair Transplant System Market: Overview

The ARTAS robotic hair transplant system market is growing at a fast pace as these systems are quite efficient and make the entire procedure more comfortable. Higher adoption of robotic hair transplant treatment over traditional, more time-consuming treatments has given a boost to the overall market of ARTAS robotic hair transplant system.

Robotic Hair Transplant System Market: Regional Outlook

Geographically, the global robotic hair transplant system market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America dominates the robotic hair transplant system market due to the rapid technological advancements and better healthcare facilities.

It is followed by Europe because of high adoption among end-users. Asia-Pacific is expected to witness fast expansion in robotic hair transplant system market due to increasing prevalence of skin-related disorders and growth in healthcare infrastructure. Middle East and African regions will witness sluggish growth because of a lack of awareness among people and the high cost of the treatment.

Robotic Hair Transplant System Market: Key Players

Restoration robotics Inc. is the manufacturer of ARTAS robotic hair transplantation systems, which was FDA approved in 2011. Other manufacturers are also focusing on developing other robotic hair transplant systems.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America
    • US
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Peru
    • Rest of LATAM
  • Europe
    • EU – 4 (Germany, France, Italy, Spain)
    • UK
    • BENELUX (Belgium, Netherlands, Luxemburg)
    • NORDIC (Norway, Denmark, Iceland, Sweden)
    • Eastern Europe (Poland, Ukraine, Czech Rep. etc.)
    • Rest of Europe
  • CIS & Russia
  • Japan
  • APEJ
    • Greater China
    • India
    • Korea
    • ASEAN Countries
    • Rest of APEJ
  • Middle East & Africa
    • GCC Countries
    • Turkey
    • Iran
    • Israel
    • South Africa
  • Rest of MEA

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Robotic Hair Transplant System Market Forecast, Trend Analysis & Competition Tracking – Global Review 2018 to 2028

Source

Previous Posts

Arena Starts Phase II Alopecia Areata Study on Etrasimod

Arena Starts Phase II Alopecia Areata Study on Etrasimod

Arena (ARNA) Starts Phase II Alopecia Areata Study on Etrasimod

Arena Pharmaceuticals, Inc. ARNA announced that it has dosed first patients in a phase II study to evaluate its key pipeline candidate — etrasimod — as a potential treatment for moderate-to-severe alopecia areata. The study will evaluate the 2mg dose of the candidate for efficacy and safety over 24 weeks.

The primary endpoint of the phase II study is the percent change in the Severity of Alopecia Tool (“SALT”) score from baseline. Data from the study is anticipated in 2021.

The candidate has demonstrated the potential to reduce inflammation and restore hair growth in earlier stage studies.

Shares of Arena have gained 50.5% year to date compared with the industry’s increase of 2.7%.

Alopecia areata is an autoimmune dermatologic condition that results in patchy non-scarring hair loss, usually affecting the scalp. There is no FDA approved drug presently available to treat this condition, which can lead to high levels of depression and anxiety in patients.

Pfizer PFE is another company developing an oral JAK3 inhibitor candidate, PF-06651600 for Alopecia areata in a pivotal study.

Apart from alopecia areata, Arena is developing etrasimod in other indications as well. The candidate is presently in late-stage development for ulcerative colitis (“UC”).

Arena is currently enrolling patients in two pivotal phase III studies — ELEVATE UC 52 and ELEVATE UC 12 — evaluating etrasimod for treating moderately-to-severely active UC.

A phase IIb study — ADVISE — is evaluating etrasimod in patients with atopic dermatitis (“AD”). Data from the study is expected later this year. Another phase IIb study — CULTIVATE — was initiated earlier this year to evaluate the candidate in Crohn’s disease. The company has plans to start a mid-stage study to evaluate the candidate for eosinophilic esophagitis, a gastro-intestinal disease by year-end.

Arena has another key pipeline candidate, olonarib. The phase II CAPTIVATE study is evaluating olaparib as a treatment for abdominal pain associated with irritable bowel syndrome. Data from the study is expected later this year.

We note that Arena is progressing well with its key pipeline candidates. However, the company will face stiff competition from multiple approved drugs in their targeted indications.

There are several drugs approved for treating UC including AbbVie’s ABBV multi-billion dollar drug, Humira. Sanofi/Regeneron’s REGN Dupixent is one of the top drugs approved for treating AD.

Moreover, olaparib, following potential approval, will compete with AbbVie/Ironwood Pharma’s Linzess.

Arena (ARNA) Starts Phase II Alopecia Areata Study on Etrasimod

Source

Previous Posts

Alopecia Treatment Market

Research on Alopecia Market

Research on Alopecia Market (impact of COVID-19) 2020-2026


In this study, we have issued the much-needed information on the Global Alopecia Market 2020 which covers detailed information about the Alopecia market size, Alopecia market trends, industrial dynamics and Alopecia market share.

Furthermore, it drops light on the series of instantly changing Alopecia market scenarios as well as the upcoming assessment of numerous factors that completely impacting the global Alopecia market report.

The research on the world Alopecia market illustrates the whole international market alongside a detailed analysis of the revenue growth and profitability of the Alopecia market.

The latest report on the worldwide Alopecia market represents a comprehensive understanding of the futuristic Alopecia market estimations, based on the historical and current predictions. It is considered to be the significant and professional document that especially focusing on the Alopecia market drivers, size, leading segments and topological zones.

Moreover, the report splits the global Alopecia market size by volume and value on the basis of product types, applications, well-established vendors and major geographies.

Pivotal industry players involved in this report are:

Lifes2good
Kirkland Signature
Johnson & Johnson
Dr Reddy’s Laboratories.
Cipla.
Alpecin.
Vitabiotics.
Sun Pharma.
Phyto Ales Group

The Global Alopecia market divided by product types:

Oral treatment
Topical treatment
Other treatment

Alopecia market segregation by application:

Male
Female

In the recent research document, we have listed out a wide range of business policies, mergers & acquisitions, collaborations, upcoming as well as trending innovative techniques. It also demonstrates systematic information and analysis related to the Global Alopecia market trends, growth factors, share, segments, challenges, opportunities and forecasts details from 2020 to 2026.

The global Alopecia market report showcases several factors that are driving the industrial growth and meanwhile, evaluates the present market scenario, insightful details and new updates about the corresponding segments involved in the Alopecia market report. It also sheds light on the price trends, demand and supply ratio, historical as well as forecasted industry data, and company shares of the top Alopecia market players by geography.

The report has been designed with the help of series of methodologies and essential techniques like SWOT analysis, Porter’s Five Forces analysis, graphical representation, pie charts and real-time analytics are helpful to add more precise and clear understanding about the Alopecia market-related facts and figures.

Research on Alopecia Market (impact of COVID-19) 2020-2026

Source

Previous Posts

Global Alopecia Treatment Industry Research Report

Alopecia Market

Alopecia Market

Market Summary

The Alopecia Market is expected to reach USD 12.99 Billion by 2026, according to a new report by Reports and Data. This can be mainly associated with the rising predominance of chronic disorders such as hyperthyroidism, hypothyroidism, acute stress disorder, lupus, and hypo pituitarism.

Moreover, increasing incidence of Hodgkin’s disease, Hashimoto’s disease, Addison’s disease, and celiac disease along with factors such as access to treatment quickly are expected to drive the market growth.

However, the high cost of treatment and adverse side effects is expected to restrain the growth. Also, changing lifestyle such as consumption of tobacco, an increase in the use of alcohol, and other associated products, growing stress levels, and the expanding population are expected to spur the market. Increasing disposable incomes coupled with expanding emphasis on aesthetic appearance are also likely to add to the demand for alopecia treatment worldwide.

Hair loss, also acknowledged as alopecia or baldness refers to a loss of hair from part of the head. The typical pattern of hair loss can vary from a small area to the entire body. Scarring or inflammation is not present. Hair loss in some people may cause psychological distress.

General types include female-pattern hair loss, male-pattern hair loss, alopecia areata, and a thinning of hair also known as telogen effluvium. The cause of male-pattern hair loss is a combination of male hormones and genetics, the purpose of female pattern hair loss is not clear, the use of alopecia areata is auto-immune, and the cause of telogen effluvium is mostly a psychological or physically stressful event.

The rising number of the introduction of new drugs, consumer disposable incomes, and the complementary initiatives taken by the relevant organizations namely, AHLA and NAAF, are the crucial factors for the North America region to account for the largest market share of 22.30% in 2018.

Key Coverage of the Report

Region and country wise statistics of Alopecia Market from the period 2016-2026. While 2016-2017 has been utilized as historical data, 2018 is considered the base year. 2019-2026 have been derived as forecasts.
Estimation of the market size along with historic and forecasted trend analysis.
Various Cure Types of Alopecia Market technique have been analyzed. Statistical analysis has been conducted on obtaining the individual share of these segments.
Regional up-coming Alopecia Market outlook.
Regional prevalence of the market has been mapped.
Demand and Supply GAP Analysis
Regional Competitors Pricing Strategy
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments.

Salient Trends of the Alopecia Market

The market is projected to grow at a CAGR of 1% in terms of value and reach USD 12.99 billion in 2026.
Based on disease type, the alopecia market is classified into androgenetic alopecia, alopecia areata (AA), and others. Androgenetic type led this market in 2018 with the largest revenue of USD 3.65 billion in 2018 and is expected to grow at a favorable rate over the forecast period.
Alopecia areata is an autoimmune skin disease identified by hair loss on the scalp, face, and other areas of the body. Alopecia areata is segmented into totalis, patchy, and universalis further.
The rising predominance of alopecia areata owing to autoimmune diseases such as diabetes, hyperthyroidism, and Down’s syndrome is expected to drive demand over the forecast period.
Increasing predominance coupled with rising awareness regarding aesthetic appeal and physical appearance is also assumed to drive market growth in the next few years.
Alopecia areata is expected to be the fastest-growing market with a CAGR of 5.2% during the forecast period.
Steroid injections may treat alopecia areata in the affected area, but these need to be continuously repeated to be effective. Hair loss is a common problem. The pattern of hair loss by age 50 affects about half of males and a quarter of females. About 1-2% of people develop alopecia areata at some point in time.
Male-Pattern Hair Loss (MPHL) or Androgenetic alopecia is associated with various medical conditions such as diabetes, coronary heart disease, obesity, prostate cancer, hypertension, and Polycystic Ovary Syndrome (PCOS).
Also, the availability of treatments such as oral treatments, licensed topical treatments involving the use of finasteride and minoxidil; and surgical procedures such as hair replacement and transplantation are expected to drive the market.
Laser treatments are also becoming common for non-invasive approach. Such non-invasive treatment approaches are also likely to drive the androgenetic segment.
The global Alopecia Market is growing at a rapid speed owing to the increase in stress and changed lifestyle.
The market can be classified into home care settings and dermatology clinics, based on application. Dermatology clinics account for the largest market share of 54.24% in 2018 and are anticipated to grow at a fruitful rate over the forecast period.
Dermatology clinics coupled with innovative technologies and prescription hair care products help many affected individuals fight their condition.
Consultation with dermatologists is regarded as the best option for the treatment, as they prescribe suitable medication or therapy for effective results. These factors are responsible for the high need for dermatology clinics for hair loss treatment.
On the other hand, treatment in home care settings is expected to grow at a rate of 5.1% during the forecast period.
Prescription medicine segment is anticipated to grow owing to increasing disposable income and quickly changing lifestyle. Finasteride and Corticosteroids are some of the majorly prescribed medications.
Based on the sales distribution, the market is segmented into prescription-based medications or treatment devices and Over the Counter (OTC).
Sale of prescription products account for the larger market share of 68.85% in 2018 and is estimated to reach USD 5.95 billion by 2026.
The OTC segment is expected to grow at a rate of 5.1% during the forecast period.
Increasing R&D efforts to improve treatments, FDA approvals obtained for certain products and strategic initiatives taken by the key players, are the primary competitive strategies paving the way for market expansion.
In April 2016, Johnson & Johnson announced the launch of a new global healthcare initiative to implement healthcare solutions, in Africa.
The developing prosperity of countries such as Indonesia, Taiwan, China, and India is inviting new international ventures in these countries thereby leading to the growth of various industries in the APAC region.

Companies considered and profiled in this market study

Cipla Inc., Johnson and Johnson AG, Transitions Hair Pty Ltd., Sun Pharmaceutical Industries Ltd., Merck & Co., Inc.,  Cirrus Hair Centers, Lexington International LLC,  Vita-Cos-Med Klett-Loch GmbH, Follica, Inc., and Capillus.

Market-O-Nomics

Rising demand for low-cost treatment, growing awareness regarding adverse effects of prescribed drugs, and the increasing availability of options are spurring the need for OTC products.
Moreover, a surge in the number of FDA-approved OTC products for hair loss treatments is additionally expanding their demand. Some of the FDA-approved OTC products for hair loss treatment are Oscar Blandi hair lift instant thickening and strengthening serum and Keranique hair regrowth system.
In 2018, the dominant gender segment for the alopecia market is women that accounts for the larger market share of 56.48%. The growing awareness amongst women about alopecia and the importance laid upon appearance by them are the key drivers of this segment.
Due to the predominance of a vast number of new entrants, established manufacturers, and suppliers in the market, the industry is extremely competitive.
Asia Pacific is forecasted to witness the fastest CAGR of 5.4% during the forecast period. A vast population suffering from alopecia and growing awareness about the available therapeutic options are the key growth drivers.
Economic development coupled with continually increasing per capita healthcare investment in emerging countries such as India, China, and Singapore is expected to create high growth opportunities.
Innovations and technological trends in treatment, evolving healthcare expenditures, and increased healthcare facilities are expected to drive the growth further.

Segments Covered in the report:

This report forecasts revenue growth at a global, regional & country level, and provides an analysis on the industry trends in each of the sub-segments from 2018 to 2026.

For the purpose of this study, Reports and Data have segmented the global Alopecia Market on the basis of Disease, Gender, application, Sales distribution and region:

Disease Outlook (Revenue, USD Million; 2016-2026)

Alopecia Areata
Androgenetic Alopecia
Others

Sales distribution Outlook (Revenue, USD Million; 2016-2026)

Prescriptions
OTC

Application Outlook (Revenue, USD Million; 2016-2026)

Homecare Settings
Dermatology Clinics

Gender Outlook (Revenue, USD Million; 2016-2026)

Female
Male

Regional Outlook (Revenue, USD Million; 2016-2026)

North America
U.S.
Europe
Germany
UK
Asia Pacific
China
India
Southeast Asia
Latin America
Brazil
Middle East & Africa

Source

Previous Posts

Alopecia Treatment Market

Alopecia Drugs Market Summary

Alopecia Drugs Market Summary, Trends, Sizing Analysis and Forecast To 2025

According to the latest research report on “Global Alopecia Drugs  Market” report provides information related to market size, production, CAGR, gross margin, growth rate, emerging trends, price, and other important factors.

Focusing on the key momentum and restraining factors in this market, the report also provides a complete study of future trends and developments in the market.

The Alopecia Drugs report contains all the details of the expected market dynamics and new market opportunities due to the COVID-19 outbreak. Stratagem Market Insights tried to cover all the market analysis of annual economic growth in the latest report on the Alopecia Drugs market.

According to analysts, the growth of the Alopecia Drugs market will have a positive impact on the global platform and will witness gradual growth over the next few years. This report study incorporates all the market growth and restraining factors along with the important trends mentioned between 2020 and 2025.

Market segmentation:

The Alopecia Drugs market has been segmented into a variety of essential industries including applications, types, and regions. In the report, each market segment is studied extensively, taking into account market acceptance, value, demand, and growth prospects. Segmentation analysis allows customers to customize their marketing approach to make better orders for each segment and identify the most potential customers.

Market Segmentation by Application:

Men and Women

Market Segmentation by Product:

Oral
Topical and Injectable

Competitive Landscape

This section of the report identifies various major manufacturers in the market. It helps readers understand the strategies and collaborations players are focusing on fighting competition in the marketplace. The comprehensive report gives a microscopic view of the market.

The reader can identify the manufacturer’s footprint by knowing about the manufacturer’s global revenue, the manufacturer’s global price, and the manufacturer’s production during the forecast period.

The major manufacturers covered in this report:

Helix BioMedix
Merck
GlaxoSmithKline
The Himalaya Drug Company
Johnson & Johnson
Dr. Reddy’s Laboratories Ltd
AndroScience
Bayer HealthCare
Aqua Pharmaceuticals and Cipla Inc

Regional Insights of Alopecia Drugs  Market:

In terms of geography, this research report covers almost all major regions around the world such as North America, Europe, South America, Middle East, Africa, and the Asia Pacific. Europe and North America are expected to increase over the next few years.

Alopecia Drugs markets in the Asia-Pacific region are expected to experience significant growth during the forecast period. Advanced technology and innovation are the most important characteristics of North America and the main reason why the United States dominates the world market. The Alopecia Drugs market in South America is also expected to expand in the near future.

Years considered for this report:

Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

Important Facts about Alopecia Drugs  Market Report:

Market share valuations of the segments on the country and global level
Share analysis of the major market players
Opportunities for new market entrants
Market forecast for a minimum of six years for all the segments, sub-segments in various countries and regions
Market Trends (drivers, restraints, opportunities, threats, challenges, investment opportunities, and approvals)
Strategic endorsements in key business segments on the basis of market valuations
Competitive scenario mapping the key development patterns.
Company profiling with comprehensive strategies, financial details, and recent progressions.
Supply chain trends representing the latest technological advancements.

Questions Answered by the Report:

What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving the Global Alopecia Drugs  Market?
What are the challenges to market growth?
Who are the key vendors in space?
What are the key market trends impacting the growth of the Global Alopecia Drugs  Market?
What are the key outcomes of the five forces analysis of the Global Alopecia Drugs  Market?

Alopecia Drugs Market Summary, Trends, Sizing Analysis and Forecast To 2025

Source

Previous Posts